Identification of prognostic factors in advanced epithelial ovarian carcinoma.
about
Optimal primary surgical treatment for advanced epithelial ovarian cancerOvarian cancer standard of care: are there real alternatives?Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignanciesIncorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancerNeoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopyMolecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients.A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.Signature of a silent killer: expression profiling in epithelial ovarian cancer.Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.Comparative effectiveness research in gynecologic oncology.Under-treatment of elderly patients with ovarian cancer: a population based study.Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.Integrated care in ovarian cancer “IgV Ovar”: results of a German pilot for higher quality in treatment of ovarian cancerAngiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.En bloc pelvic resection for advanced ovarian cancer preceded by central ligation of vessels supplying the tumor bed: a description of surgical technique and a feasibility study.Can subjective global assessment of nutritional status predict survival in ovarian cancer?Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.The optimal time for surgery in women with serous ovarian cancer.Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer.External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancerRecent surgical management of ovarian cancer.Considerations in the surgical management of ovarian cancer in the elderly.Predictors of ovarian cancer survival: a population-based prospective study in Sweden.Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery.Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience.BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
P2860
Q24234923-D0EB8B35-6798-4EA1-B9C7-507F5401A62CQ26862249-C6C8FDEB-6532-4BD6-9A33-5F1E294D6376Q27026896-C5250D32-1011-4AAB-AA46-F03F19FE281BQ30975500-5A6818C3-8CF8-4CBE-8ACD-B1CA355BE3E1Q33397995-B9FF3197-DFB0-4DDF-9F11-79EA3818980BQ33461909-2148F51B-AF4C-4A6E-8750-18DE9CA76B75Q33748623-0BDA8655-3F8D-4E63-9A1B-922810D099C0Q34207789-EB76C93C-5104-458D-B64F-91F4656A8AAEQ35176826-430D93A4-64AE-46A1-BB6C-8E9E68025889Q35294575-5EDE8DEB-7A40-4954-BE30-B59B7FF2A105Q35680306-A88D2BD8-E454-45B6-8DF5-B9B4D3698E89Q35692182-7F450120-5EAC-468E-8148-CA76EEED6AC0Q35793038-ED6DBBAD-915D-462C-A1B6-7CC723EF4961Q35853767-3B6D936B-3274-4B95-9783-E47EBE50852DQ35996680-BC55DEDF-BEA8-4485-8CBC-38B25A48E6EBQ36474863-5705A097-5DEE-43FB-98D4-038110311DC1Q36613817-BD506D63-01C8-4799-A6E6-08F6D8425D24Q36681153-551BA6E9-2EF9-4B7D-BD01-640AD3F7F815Q36850922-511B0296-10D6-43FA-BAD8-FC09E1D4A19AQ36975256-DD710AF9-28E1-4A12-B8FA-BD255A838971Q36979335-C6E20FFA-51B0-46ED-8AAE-8114E025D2F2Q37127385-2F23BF08-17D3-447D-85E1-E732BB975683Q37433018-91C07877-7A18-4A0D-98EC-4CB2C3D67A43Q37459671-C49C8659-048D-4772-9F19-13A18E73FCB9Q37861289-3872FC4B-6B9E-483A-8A64-795F0D18C3D2Q38063818-2F85B2B0-65F6-4D6C-9A6A-ECD877468099Q43567397-06C45778-D4E5-41EA-8154-D43DF603A755Q43735818-C048A709-1817-4368-8813-CC5A50EC4F3FQ43992111-6A42C4B9-93A9-4EA3-AECB-423784B926BEQ46483826-370368B1-82E2-4368-A062-81D852434ACEQ47281811-0B62B9AF-DD55-4B37-8C91-909A377724D5Q47346032-3C14E9BF-ACCE-4188-9C2E-1940DB648138Q50213512-E3C82011-072C-4855-A3B1-D572BBE0AAECQ53189566-8CBDA2B2-335B-4DD9-8993-D62E6CCF2C0FQ54219747-4801447A-121B-4B87-9F91-7A3C0D0BEEC3
P2860
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@ast
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@en
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@nl
type
label
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@ast
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@en
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@nl
prefLabel
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@ast
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@en
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@nl
P2093
P356
P1433
P1476
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
@en
P2093
Bhaskaran D
Hensley ML
Hoskins WJ
Venkatraman ES
P304
P356
10.1006/GYNO.2001.6328
P407
P577
2001-09-01T00:00:00Z